CRL
Charles River Laboratories Inte
Healthcare · in the S&P 500
📍 Wilmington, United States · See it on the company map
The shape of the figures
Each spoke is one ratio. Further out means a higher figure than more of the index — not a better one. A high P/E or high debt sits far out too, so the size of the shape is not a score.
Drag to turn the shape. Tap or point at a dot to read the figure behind it.
The figures and what each one means are below. A hollow dot means the company doesn't report that figure.
Figures from the annual reports are unavailable right now — please try again in a minute.
Key figures, against the S&P 500
Figures as of 9 Nov 2026, refreshed weekly
Each bar places this company among the S&P 500 companies that report that figure. Further right means a higher figure — not a better one. Whether higher or lower suits you depends on what you are looking for, so the bars don't add up to a score.
Valuation
P/E ratio?
381.4x
The share price is 381.4 times the last twelve months' earnings per share.
P/E on average earnings?
81.4x
The share price is 81.4 times earnings per share averaged over recent years.
Price / book
5.2x
The market values the company at 5.2 times the accounting value of its equity.
EV / EBIT?
2,507.7x
The company's value including its debt is 2,507.7 times its operating profit.
Free cash flow yield?
2.6%
Free cash flow equals 2.6% of the company's market value.
Profitability
Return on equity?
1.3%
Each 100 of shareholders' money produced 1.3 of net profit.
Return on assets?
4.7%
Each 100 of assets produced 4.7 of net profit.
Return on invested capital
0.1%
Each 100 invested by lenders and owners produced 0.1 of profit.
Operating margin?
0.2%
Of every 100 in sales, 0.2 was left as operating profit.
Debt
Debt / equity?
87.1%
Total debt equals 87% of shareholders' equity.
Net debt / EBITDA?
2.9x
Net debt equals 2.9 years of operating earnings (EBITDA).
Interest cover
0.1x
Operating profit was 0.1 times the interest bill.
Growth
Revenue growth
-0.9%
Latest revenue is 0.9% below the average of earlier reported years.
Earnings growth
-144.6%
Latest net profit is 144.6% below the average of earlier reported years.
⚠️ Not financial advice
This is a personal project, not professional investment research. The underlying market data may be delayed or incorrect. Nothing here is a recommendation to buy or sell any security. Always do your own research and consult a qualified professional before investing.
This tool is for informational and planning purposes only. It does not constitute financial, investment, tax or legal advice. Always consult a qualified professional before making financial decisions.